There are currently two HPV vaccines on the market, but if there was any regard for sound scientific evidence, neither would be promoted as heavily as they are. The first, Gardasil, was licensed by the FDA in 2006. It is now recommended by doctors, as well as Planned Parenthood as a routine vaccination for females aged 9-26 and males 11-21 in the US. The second HPV vaccine, Cervarix, was approved in 2009.
For those celebrating the new HPV vaccine, the nation’s leading cancer research centers just released a public endorsement of recent recommendations by the CDC regarding the use of the vaccine. This is potentially great news for those suffering from HPV, which is the most widespread sexually transmitted disease in the United States. However, some skeptics believe it may be more of a foe than a friend.
Many women are not aware that the HPV vaccine Gardasil might actually increase their risk of cervical cancer. Initially, that information came straight from Merck and was presented to the FDA prior to approval. According to Merck’s own research, if you have been exposed to HPV strains 16 or 18 prior to receiving the Gardasil vaccine, you could increase your risk of precancerous lesions or cervical cancer tissue by as much as 44.6 percent.
Other health problems associated with the Gardasil vaccine include immune-based inflammatory neurodegenerative disorders, suggesting that something is causing the immune system to overreact in a detrimental way—sometimes fatally.
- Between June 1, 2006 and December 31, 2008, there were 12,424 reported adverse events following Gardasil vaccination, including 32 deaths. The girls, who were on average 18 years old, died within two to 405 days after their last Gardasil injection
- Between May 2009 and September 2010, 16 additional deaths after Gardasil vaccination were reported. For that timeframe, there were also 789 reports of “serious” Gardasil adverse reactions, including 213 cases of permanent disability and 25 diagnosed cases of Guillain-Barre Syndrome
- Between September 1, 2010 and September 15, 2011, another 26 deaths were reported following HPV vaccination
- As of May 13, 2013, VAERS had received 29,686 reports of adverse events following HPV vaccinations, including 136 reports of death, as well as 922 reports of disability, and 550 life-threatening adverse events
Additionally, in January, 2016, the American College of Pediatricians released a report highlighting concerns that Gardasil may be associated with a rare but serious condition, known as premature ovarian failure (POF).
The Controversy of the HPV Vaccine
69 National Cancer Institute-selected cancer centers sent a letter to the CDC opposing its HPV vaccine recommendations. Among these organizations were the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and The University of Maryland Marlene, often touted as pioneers in innovative cancer studies, and notable authorities on vaccine research.
Some of these controversial recommendations propose that children aged 11 to 12, under the new CDC guidelines, should obtain two doses of the HPV vaccine no less than six months apart. A three-dose series is recommended for young adults 15 and older. The CDC stands by these recommendations due to the approximately 79 million individuals in the US that are afflicted with HPV.
Those in opposition are worried that these numbers seem to be continually increasing rather than decreasing, as would be expected with the implementation of the vaccine. The CDC reports that over 39,000 different cancers connected to HPV are found each year in the United States.
Whereas, Dr. Konno of Japan explains that the Japanese administration ended its recommendation for the HPV vaccine in 2013, after several documented cases of adverse effects in young women who had negative stigmas regarding the vaccine. Dr. Konno stands by the fact that the side effects are merely a “psychological effect,” and that the whole controversy was started by an anti-vaccine group.
The Japanese newspaper Asahi Shimbun offered facts in regards to some 50 girls who experienced complex regional pain disorder. The paper also printed the statistic that 100 girls stayed home from school after getting the HPV vaccine.
Friend or Foe?
According to Dr. Konno, it is hard to know if the HPV vaccine is friend or foe due to the sensationalized media reports. This is because the negative story about the HPV vaccine spread through Japanese social networks without being independently verified.
In Central and South America, some might call it a foe, due to deaths related to the vaccine. Karen Durán-Cantor, on May 22, 2015, fell victim to the vaccination. This 16-year old girl died after difficulties due to new onset autoimmune disorders believed to have been caused by receiving two doses of Gardasil. The vaccine is given to school age girls all over the country.
She began to experience joint and finger pain, which the treating physicians believed was caused by Juvenile Rheumatoid Arthritis. Despite receiving medical treatment, her symptoms became so severe she had to quit going school due to the constant excruciating pain.
There are reports of similar cases in the United States. On July 30, 2014, 12-year-old Meredith Prohaska of Waukesha, Wisc., died only hours after being inoculated with the Gardasil HPV vaccine. Inquiring minds wanted to know if the vaccine was the cause of her death. Federal officials and many doctors profiting from kickbacks argued that it was not.
Every single confirmed fatality has been independently reviewed by both the CDC and FDA. In every instance, both institutions unanimously concluded there was “no diagnosis that would propose that Gardasil triggered the death.”
Cover-up or not?
Many researchers, as well as Meredith’s parents, are not satisfied with their findings and believe that not only did the HPV vaccine kill Meredith, but that there was indeed a cover-up. Her mother found her unresponsive body lying face-down only six hours after being inoculated. In Oct. 2014, the Waukesha County medical inspector publically announced that the autopsy revealed no evidence that the vaccination caused or contributed to the girl’s death, prior to that, the cause of her death had been ruled “inconclusive.”
Earlier this year, a lab scientist, who discovered HPV DNA fragments in the blood of a teenage girl who died after receiving the Gardasil vaccine, published a case report in the peer reviewed journal Advances in Bioscience and Biotechnology.
The otherwise healthy girl died in her sleep six months after receiving her third and final dose of the HPV vaccine. A full autopsy revealed no cause of death. Sin Hang Lee with the Milford Molecular Laboratory in Connecticut confirmed the presence of HPV-16 L1 gene DNA in the girl’s postmortem blood and spleen tissue. These DNA fragments are also found in the vaccine. The fragments were protected from degradation by binding firmly to the particulate aluminum adjuvant used in the vaccine.
“The significance of these HPV DNA fragments of a vaccine origin found in post-mortem materials is not clear and warrants further investigation,” he wrote.
Lee suggests the presence of HPV DNA fragments of vaccine origin might offer a plausible explanation for the high immunogenicity of Gardasil. This means that the vaccine has the ability to provoke an exaggerated immune response, which can be deadly in even an otherwise healthy young adult. He also points out that the rate of anaphylaxis in girls receiving Gardasil is far higher than normal—reportedly five to 20 times higher than any other school-based vaccination program. Anaphylaxis is a severe allergic reaction that can be deadly, often referred to as anaphylactic shock.
On February 28, 2013 the government watchdog group Judicial Watch announced it had filed a Freedom of Information Act lawsuit against the Department of Health and Human Services to obtain records from the Vaccine Injury Compensation Program related to the HPV vaccine. The lawsuit was filed in order to force the DHHS to comply with an earlier FOIA request, filed in November 2012, which had been ignored.
“Judicial Watch wants all records relating to the VICP, any documented injuries or deaths associated with HPV vaccines and all records of compensation paid to the claimants following injury or death allegedly associated with the HPV vaccines… The number of successful claims made under the VICP to victims of HPV will provide further information about any dangers of the vaccine, including the number of well-substantiated cases of adverse reactions.”
On March 20, Judicial Watch announced it had received the FOIA documents from the DDHS, which revealed that the National Vaccine Injury Compensation Program has awarded $5,877,710 to 49 victims for harm resulting from the HPV vaccine.
This new information from the government shows that the serious safety concerns about the use of Gardasil have been well-founded,” said Judicial Watch President Tom Fitton. “Public health officials should stop pushing Gardasil on children.”
Meanwhile, a coalition of doctors and universities continues to declare the vaccine is completely harmless. To ease people’s minds and counter what they consider “negative publicity,” they plan on highlighting the CDC endorsement of the vaccine and educating patients on the “lack of evidence” supporting some of the associated stigmas. In the meantime, they are actively encouraging all teenagers to take advantage of this “safe and effective” vaccine. They have also launched an aggressive PR campaign, whose aim seems to be to scare parents into getting their children vaccinated, as evidenced by this fear-mongering ad from Utah University below.
There can be no doubt that we are in urgent need of a serious vaccine safety review in the US. Quality research and thorough evaluation are simply not being done. And very few vaccine recommendations, which prop up state vaccine mandates, stand on firm scientific ground.
Your right to vaccine exemptions is also increasingly under threat. Listening to the impassioned pleas for mandatory HPV vaccination makes me wonder if its advocates were not all caught up in a fervor, rather than thinking rationally – and whether they are even aware of what the science says about HPV efficacy and adverse side effects.